HIV/AIDS is making a comeback in parts of Zambia one year after American cuts to the PEPFAR program, which has saved millions of lives across Africa since 2003, according to the New York Times. Health officials are documenting rising infection rates and treatment disruptions, warning that decades of progress could be reversed.
The President's Emergency Plan for AIDS Relief, launched by President George W. Bush, represented one of America's most successful foreign development programs, providing antiretroviral medications and prevention services to more than 20 million people globally. At its peak, PEPFAR funding exceeded $6 billion annually, making the United States the world's largest contributor to global HIV/AIDS response.
To understand today's headlines, we must look at yesterday's decisions. PEPFAR enjoyed bipartisan support in Washington for two decades, with successive administrations maintaining or expanding funding despite budget pressures. However, domestic political controversies over reproductive health services and foreign aid skepticism led to significant budget reductions beginning in 2024, with particularly sharp cuts to African programs.
Zambian health facilities are reporting medication stockouts and reduced testing capacity as PEPFAR funding declines. Community health workers who previously conducted outreach and education programs have been laid off, while clinics that provided free antiretroviral therapy now ration supplies. The deterioration is most pronounced in rural areas where government health systems lack resources to compensate for lost American support.
Public health experts warn that interruptions in antiretroviral treatment allow the virus to develop drug resistance, potentially creating strains that are harder to treat and control. Patients who discontinue medication due to supply shortages may experience viral rebound, increasing both their health risks and the likelihood of transmission to others.
The situation in Zambia reflects broader patterns across sub-Saharan Africa, where PEPFAR has been the primary funder of HIV/AIDS programs. Countries including Kenya, Malawi, and Tanzania have reported similar challenges as American funding declines. The Global Fund to Fight AIDS, Tuberculosis and Malaria has attempted to fill gaps but lacks resources to fully replace PEPFAR's contributions.
